KCNA3 and metabolic syndrome: In this line, our previous research in the MetS/T2DM model shows that local Kv1.3 blocker treatment after carotid ligation ameliorates vessel remodeling and eliminates HFD-induced insulin resistance and weight gain (Arevalo-Martinez et al., 2021).